Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

Autor:	Agostino Cortelezzi, Ivo Nnane, Guillermo Garcia-Manero, Mariëlle Beckers, Vadim A Doronin, Brayan Merchan, María Díez-Campelo, Helen Varsos, Nikki A. Deangelis, Matteo G. Della Porta, Koen Van Eygen, Liang Xiu, Dimitri Breems, Esther Rose, Edo Vellenga, Valle Gomez, Meagan A. Jacoby
Přispěvatelé:	Guided Treatment in Optimal Selected Cancer Patients (GUTS), Stem Cell Aging Leukemia and Lymphoma (SALL)
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	medicine.medical_specialty business.industry Internal medicine Myelodysplastic syndromes Transfusion dependence MEDLINE Medicine Daratumumab Hematology business medicine.disease
Zdroj:	American Journal of Hematology, 96(4), E111-E114. Wiley
ISSN:	0361-8609
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1980eea6ad28973e30ed9207097e167 https://hdl.handle.net/11370/29d11ec0-2ba1-4d5d-83b2-82bdc660fdad Zobrazit plný text záznamu Plný text